Frontier Science Scotland
Frontier Science Scotland (FSS) is an independent, not-for-profit contract research organization based in the Scottish Highlands, collaborating globally since 2002 with researchers from pharmaceutical companies, academia, and health services. Its mission is to provide effective, agile solutions in clinical trial design, conduct, and analysis, advancing knowledge and public benefit through collaboration, integrity, and continuous learning. FSS specializes in data management, biostatistics, and quality services, with a vision to be a globally recognized center of excellence in clinical trial services.
Industries
Nr. of Employees
small (1-50)
Frontier Science Scotland
Kincraig, Highland, United Kingdom, Europe
Services
Design and delivery of clinical trial databases, CRF/EDC development, data cleaning, query resolution, medical coding support and processes to reach database lock.
Statistical design, programming and analysis for clinical trials including sample size calculation, SAPs, CDISC dataset creation, TFL production and regulatory-ready reporting.
Quality management system support, GCP compliance, auditing of study conduct, TMF services and technical writing for quality and regulatory documentation.
Risk-based remote and onsite monitoring, quality control oversight and Trial Master File management to ensure protocol and regulatory adherence.
Statistical authorship, data provision and manuscript support for peer-reviewed publications and academic dissemination of trial results.
Support for data subject rights and cross-border data protection enquiries through an appointed EU/EEA data protection representative and internal contact pathways for UK data subjects.
Design and delivery of clinical trial databases, CRF/EDC development, data cleaning, query resolution, medical coding support and processes to reach database lock.
Statistical design, programming and analysis for clinical trials including sample size calculation, SAPs, CDISC dataset creation, TFL production and regulatory-ready reporting.
Quality management system support, GCP compliance, auditing of study conduct, TMF services and technical writing for quality and regulatory documentation.
Risk-based remote and onsite monitoring, quality control oversight and Trial Master File management to ensure protocol and regulatory adherence.
Statistical authorship, data provision and manuscript support for peer-reviewed publications and academic dissemination of trial results.
Support for data subject rights and cross-border data protection enquiries through an appointed EU/EEA data protection representative and internal contact pathways for UK data subjects.
Expertise Areas
- Clinical trial data management
- Biostatistics and statistical programming
- CDISC dataset preparation and regulatory submission
- Good Clinical Practice (GCP), QMS and clinical quality assurance
Key Technologies
- SAS
- R
- Stata
- CDISC (SDTM, ADaM)
News & Updates
We’ve been providing auditing services to NHS Scotland since 2007, contributing to improvements in Scottish hospital research sites.
Our biostatistics team seamlessly filled capacity gaps to ensure no study deadlines were missed.
Our risk-based, flexible approach helped deliver a complete and accurate database in a Norwegian clinical trial.
Our flexibility and collaborative approach led to practice-changing results in a global breast cancer trial.
We developed an agile approach to statistical analyses during a trial while the protocol was being amended.
Sub-analysis of body mass index and weight changes in HER2-positive early breast cancer patients.
We’ve been providing auditing services to NHS Scotland since 2007, contributing to improvements in Scottish hospital research sites.
Our biostatistics team seamlessly filled capacity gaps to ensure no study deadlines were missed.
Our risk-based, flexible approach helped deliver a complete and accurate database in a Norwegian clinical trial.
Our flexibility and collaborative approach led to practice-changing results in a global breast cancer trial.
We developed an agile approach to statistical analyses during a trial while the protocol was being amended.
Sub-analysis of body mass index and weight changes in HER2-positive early breast cancer patients.